Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease

Hemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD. The public dataset was acquired from the Gene Expression Omnibus database. The differentially expressed genes (DEGs...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoxin Zhang, Jieqiong Fu, Wenming Niu
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2025.2528757
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849721573118836736
author Guoxin Zhang
Jieqiong Fu
Wenming Niu
author_facet Guoxin Zhang
Jieqiong Fu
Wenming Niu
author_sort Guoxin Zhang
collection DOAJ
description Hemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD. The public dataset was acquired from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) showing opposite trends across the three groups were obtained as crosstalk genes, and their potential pathways were explored through KEGG and GSEA analyses. Next, hub genes were identified using LASSO regression, and their diagnostic potential was assessed via ROC analysis. Key immune cell populations were identified using ssGSEA. Blood samples from healthy controls (n = 10), CKD patients (n = 9), and HD-treated CKD patients (n = 7) were collected to validate hub gene expression. A total of 132 crosstalk genes were identified, with the TGF-β and KRAS signaling pathways potentially activated in the HD group. Two hub genes, SIK1 and TNFAIP6, exhibited AUC values exceeding 0.8 for diagnosing CKD and HD-treated CKD groups. Compared to the other groups, neutrophil abundance was significantly higher in CKD group and showed a strong correlation with the hub genes. External datasets and RT-qPCR validated a consistent expression trend of TNFAIP6. Therefore, TNFAIP6 may represent a potential candidate gene with biomarker relevance in CKD and HD-treated CKD. TNFAIP6 has been previously associated with the TGF-β pathway and neutrophil regulation, and its crosstalk mechanism in HD-treated CKD warrants further exploration.
format Article
id doaj-art-c88a37a5cff8429f81fcb488f4d79bbe
institution DOAJ
issn 0886-022X
1525-6049
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-c88a37a5cff8429f81fcb488f4d79bbe2025-08-20T03:11:37ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2025.2528757Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney diseaseGuoxin Zhang0Jieqiong Fu1Wenming Niu2Hemodialysis Room (Jianhua Clinic), Shijiazhuang, Hebei, ChinaHemodialysis Room (Jianhua Clinic), Shijiazhuang, Hebei, ChinaHemodialysis Room (Jianhua Clinic), Shijiazhuang, Hebei, ChinaHemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD. The public dataset was acquired from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) showing opposite trends across the three groups were obtained as crosstalk genes, and their potential pathways were explored through KEGG and GSEA analyses. Next, hub genes were identified using LASSO regression, and their diagnostic potential was assessed via ROC analysis. Key immune cell populations were identified using ssGSEA. Blood samples from healthy controls (n = 10), CKD patients (n = 9), and HD-treated CKD patients (n = 7) were collected to validate hub gene expression. A total of 132 crosstalk genes were identified, with the TGF-β and KRAS signaling pathways potentially activated in the HD group. Two hub genes, SIK1 and TNFAIP6, exhibited AUC values exceeding 0.8 for diagnosing CKD and HD-treated CKD groups. Compared to the other groups, neutrophil abundance was significantly higher in CKD group and showed a strong correlation with the hub genes. External datasets and RT-qPCR validated a consistent expression trend of TNFAIP6. Therefore, TNFAIP6 may represent a potential candidate gene with biomarker relevance in CKD and HD-treated CKD. TNFAIP6 has been previously associated with the TGF-β pathway and neutrophil regulation, and its crosstalk mechanism in HD-treated CKD warrants further exploration.https://www.tandfonline.com/doi/10.1080/0886022X.2025.2528757Hemodialysischronic kidney diseasesKRAS signal pathwaysTGF-β signal pathwayhub gene
spellingShingle Guoxin Zhang
Jieqiong Fu
Wenming Niu
Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
Renal Failure
Hemodialysis
chronic kidney diseases
KRAS signal pathways
TGF-β signal pathway
hub gene
title Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
title_full Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
title_fullStr Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
title_full_unstemmed Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
title_short Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
title_sort bioinformatics reveals tnfaip6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease
topic Hemodialysis
chronic kidney diseases
KRAS signal pathways
TGF-β signal pathway
hub gene
url https://www.tandfonline.com/doi/10.1080/0886022X.2025.2528757
work_keys_str_mv AT guoxinzhang bioinformaticsrevealstnfaip6asacandidategeneandsuggestsitspotentialcrosstalkinthetreatmentofhemodialysisinchronickidneydisease
AT jieqiongfu bioinformaticsrevealstnfaip6asacandidategeneandsuggestsitspotentialcrosstalkinthetreatmentofhemodialysisinchronickidneydisease
AT wenmingniu bioinformaticsrevealstnfaip6asacandidategeneandsuggestsitspotentialcrosstalkinthetreatmentofhemodialysisinchronickidneydisease